The global medical fluid bags market was worth around USD 3.25 billion in 2021, with a compound annual growth rate (CAGR) of approximately 6.4 percent over the forecast period.
Medical Fluid Bags Market
The global medical fluid bags market was worth around USD 3.25 billion in 2021, with a compound annual growth rate (CAGR) of approximately 6.4 percent over the forecast period. The report evaluates key drivers and opportunities for the medical fluid bags market. Also, major restraints and challenges are studied in the report that can impact the overall market expansion during the projection period. In addition.
Medical fluid bags come in a variety of sizes and are made up of an interior pouch and an outside plastic coating. The separation of these bags into an inner pouch and an exterior covering serves to protect the contents until the pouches' specified expiry date. These bags are commonly utilized in healthcare settings with a multifunctional approach to maintain proper sterilized conditions for blood samples, which helps to ensure infection-free premises, reduce disease spread, and avoid any loss of blood samples or medications. Additionally, these bags are utilized in fluid replacement treatment, which is used to ensure blood transfusions, body fluid collection, electrolyte imbalances, and the patient's healthy nutritional intake via an oral or enteral route of administration.
The demand for medical fluid bags increased significantly during the pandemic period. Increased patient populations across the world drastically increased the requirement for medical fluid bags. These bags were primely utilized for fluid collection and electrolyte supply into the body. In March 2020, the WHO issued preliminary recommendations advising intravenous fluid treatment for infected and critically ill COVID-19 patients. Furthermore, the UK Joint Anesthetic and Intensive Care & International Fluid Academy guidelines advised that critical patients get fluid treatment to address their fluid and electrolyte needs. This increased the need for IV bags during the treatment during the pandemic period, causing significant revenue growth for the global medical fluid bag market.
Growing geriatric population may boost the market growth over the forecast period
The global increase in the number of geriatric and older persons is likely to boost the market. According to the World Health Organization, the share of the world population over 60 years old is predicted to rise by 22% by 2050, reaching 2 billion people. In the year 2020, the number of persons over 60 years old outweighed children under the age of five. By 2050, 80 percent of the world's elderly will be living in low- and middle-income countries. This is a significant problem for countries throughout the world since they must guarantee that their social and health systems are capable of dealing with this demographic transformation. Chronic obstructive lung disease, diabetes, obesity, and heart disease are all frequent illnesses in older people. Geriatric syndromes refer to the rise of complicated health conditions such as urine incontinence, frailty, and cancer as people get older. As medical fluid bags are used to store blood, drain, glucose, and other liquids, it will have a significant impact on the growth of the global medical fluid bag market. Furthermore, the increase and development of numerous chronic diseases, such as obesity, cardiovascular diseases, and other associated conditions, are also driving the market.
Health hazards associated with components used in the manufacturing of medical fluid bags may impede market growth
Concerns about incorrect disposal having a negative influence on the environment, as well as difficulties linked with the usage of PVC-made medical fluid bags on patients’ overall health, might stymie market growth. Prolonged exposure to endocrine-disrupting di-(2-Ethylhexyl) phthalate (DEHP) and bisphenol-A (BPA) has been linked to major health problems, according to the National Centers for Biotechnology Information.
Increasing the use of eco-friendly materials for the manufacturing of medical fluid bags will provide better growth opportunities for the market expansion
This growing emphasis on the usage of environmentally friendly materials in the creation of medical specialty bags will have a favorable influence on the market's growth in the coming years. Because of the negative effects of DEHP-PVC medical bags on human health and the environment, PVC-free medical bags have been developed. Several governmental and private groups are encouraging the adoption of environmentally friendly materials in medical disposables to safeguard caregivers and patients from the pollution generated by PVC manufacture and disposal. To limit the quantity of waste created during ostomy treatments, vendors are also producing washable and biodegradable pouch liners, which is one of the important trends in the global medical fluid bags market.
Stringent regulatory approvals for the manufacturing of medical fluid bags pose a major challenge to the market growth
The Food and Drug Administration (FDA) in the United States oversees the development, approval, and post-approval monitoring of medical devices, counting medical fluid bags. The majority of medical fluid bags are classed as Class I medical devices, requiring manufacturers to register their businesses. In order to receive FDA clearance, medical fluid bags must also have correct labeling and fulfill the packaging standard standards of 21 CFR 175.105. Such mandatory regulatory requirements may cause a delay in product launches, limiting the arrival of new medical fluid bags in the market.
The global medical fluid bag market is categorized into product type, material, end-user, and region. Based on product type, the market is categorized into intravenous bags, blood bags, dialysis bags, and others. The material segment of the market is bifurcated into polyolefins, PVC compounds, and others. The end-user segment is further divided into ambulatory surgical centers, hospitals, blood banks, diagnostic laboratories, and others.
In November 2020, Fagron Sterile Services (FSS) introduced Intravenous (IV) Bags, which complement the company's current HYDROmorphone, fentaNYL, and midazolam brands. This introduction aided the corporation in expanding its product variety and increasing revenues.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
North America to lead the global market over the forecast period.
The Asia Pacific holds the major share of the global medical fluid bags market. This is primarily due to the high patient population, increasing prevalence of chronic diseases, large number geriatric population, and emerging healthcare infrastructure. China and India are expected to remain the major revenue contributor in the regional market owing to the huge patient population and presence of key vendors. North America and Europe are projected to contribute significant revenue to the global market during the forecast period
Major players operating in the global medical fluid bags market include Baxter International, B. Braun Medical, C.R. Bard (Becton, Dickinson, and Company), Terumo Corporation, Coloplast, Fresenius Kabi, Pall Corporation, ConvaTec, Renolit, Maco Pharma, Smiths Medical, Technoflex, and Thermo Fisher Scientific
The global medical fluid bags market is segmented as follows:
Medical fluid bags are specialized bags which are widely used in critical patient care. Thousands of individuals living with serious diseases rely on collection bags and fluid pouches as a part of their everyday lives. These bags help patients who have gone through a surgery or suffering from some serious disorders. The bags are very useful in the management of various conditions such as blood transfusion, intravenous drug therapy, body fluid collection, etc.
The medical fluid bags market is expected to witness a robust growth in the near future. The market is mainly driven by the growing geriatric population and increasing prevalence of chronic diseases. Prevalence of chronic diseases such as heart diseases, diabetes, and cancer account for the high mortality rate across the globe. These chronic diseases lead to long-term hospital stays and require vital care during a hospital stay. Growing need for parenteral nutrition among the patients owing to the difficulty in swallowing is boosting the growth of the market. However, widespread use of polyvinyl chloride with Di(2-ethylhexyl)phthalate for manufacturing of medical fluid bags may hamper the market growth over the forecast period. Growing technological advancements in the production and design of polymer bags and pouches for a diverse range of medical applications are expected to offer lucrative business opportunities in the future.
On the basis of product type, the global medical fluid bags market is divided into drain bags, blood bags, breast milk bags, dialysis bags, intravenous bags, enema bags, reagent bags, and biohazard disposable bags. Among this drain, bags segment accounted for the major revenue share in 2017 followed by blood bags. Increasing demand for blood bags in blood banks and hospitals are expected to poise the growth of blood bags segment in the coming years. Breast milk bags were the fastest growing segment due to the increasing birth rate and rising number of working women.
The end-user segment includes hospital & clinics, blood banks, homecare settings, and diagnostic centers. The blood banks segment accounted for the maximum share of the total global medical fluid bags market and is expected to grow with the highest CAGR during the forecast period. The homecare settings and hospital & clinics segments were the fastest growing segments in 2017.
Based on the geography, the global medical fluid bags market is divided into five regions North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain as the dominant region in terms of revenue generation followed by Europe. The Asia Pacific was the fastest growing market with the highest year on year growth rate. The Middle East and Africa and Latin America are expected to experience slow growth in the medical fluid bags market in the years to come.
Some of the key players in medical fluid bags market include B. Braun, Terumo, Baxter, Fresenius Kabi, Hospira, Kawasumi Laboratories, Kraton, Maco Pharma, Pall Corporation, Westfield Medical,Amsino,Coloplast, Renolit, C.R.Bard, Thermo Fisher,Sippex, Smiths Medical, Technoflex, and ConvaTec, among others.
The global increase in the number of geriatric and older persons is likely to boost the market. According to the World Health Organization, the share of the world population over 60 years old is predicted to rise by 22% by 2050, reaching 2 billion people. In the year 2020, the number of persons over 60 years old outweighed children under the age of five. By 2050, 80 percent of the world's elderly will be living in low- and middle-income countries. This is a significant problem for countries throughout the world since they must guarantee that their social and health systems are capable of dealing with this demographic transformation. Chronic obstructive lung disease, diabetes, obesity, and heart disease are all frequent illnesses in older people.
According to the Zion Market Research report, the global medical fluid bags market was worth about 3.25 (USD billion) in 2021 and is predicted to grow to around @ (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 6.4 percent.
Asia Pacific holds the major share in the global medical fluid market. This is primarily due to high patient population, increasing prevalence of chronic diseases, large number of geriatric population and emerging healthcare infrastructure. China and India are expected to remain the major revenue contributor in the regional market owing to huge patient population and presence of key vendors.
Major players operating in the global medical fluid bags market include Baxter International, B. Braun Medical, C.R. Bard (Becton, Dickinson and Company), Terumo Corporation, Coloplast, Fresenius Kabi, Pall Corporation, ConvaTec, Renolit, Maco Pharma, Smiths Medical, Technoflex, and Thermo Fisher Scientific